<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1008233978
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Actidol 1000 mg per 100 ml
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PARACETAMOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        12.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ASPIRO PHARMA LIMITED" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ASPIRO PHARMA LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2950]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Saudi Amarox
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Saudi Amarox
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        QN02BE01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine is an analgesic (it relieves pain) and an antipyretic (it lowers fever).</p><p>The 100 mL vial is restricted to adults, adolescents and children weighing more than 33 kg.</p><p>It is indicated for the short-term treatment of moderate pain, especially following surgery, and for the short-term treatment of fever.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Actidol</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic (hypersensitive) to paracetamol or to any of the other ingredients of Actidol .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic (hypersensitive) to propacetamol (another analgesic for infusion and a precursor of paracetamol).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from a severe liver disease.</p><p><strong>Take special care with Actidol </strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Use a suitable analgesic oral treatment as soon as this administration route is possible.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from a liver or kidney disease, or from alcohol abuse.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; If you are taking other medicines containing paracetamol.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; In cases of nutrition problems (malnutrition) or dehydration.</p><p>Inform your doctor before treatment if any of the above mentioned conditions apply to you.</p><p><strong>Taking or using other medicines </strong></p><p>Probenecid causes an almost 2-fold reduction in clearance of paracetamol by inhibiting its conjugation with glucuronic acid. A reduction of the paracetamol dose should be considered for concomitant treatment with probenecid,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Salicylamide may prolong the elimination t1/2 of paracetamol,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Caution should be paid to the concomitant intake of enzyme-inducing substances (</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Concomitant use of paracetamol (4 g per day for at least 4 days) with oral anticoagulants may lead to slight variations of INR values should be conducted during the period of concomitant use as well as for 1 week after paracetamol treatment has been discontinued.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Phenytoin administered concomitantly may result in decreased paracetamol effectiveness and an increased risk of hepatotoxicity. Patients receiving phenytoin therapy should avoid large and/or chronic doses of paracetamol. Patients should be monitored for evidence of hepatotoxicity. Caution should be paid to the concomitant intake of enzyme-inducing agents. These substances include but are not limited to: barbiturates, isoniazid, anticoagulants, zidovudine,</p><p>amoxicillin+clavulanic acid, carbamazepine and ethanol. Induction of metabolism of paracetamol from enzyme inducers may result in an increased level of hepatotoxic metabolites. Busulfan - busulfan is eliminated from the body via conjugation with glutathione. Concomitant use with paracetamol may result in reduced busulfan clearance. Diflunisal - concomitant diflunisal increases paracetamol plasma concentrations and this may increase hepatotoxicity.&rdquo;</p><p><strong>Pregnancy and breast-feeding </strong></p><p><strong>Pregnancy </strong></p><p>Inform your doctor if you are pregnant. Actidol may be used during pregnancy. However, in&nbsp; this case the doctor must evaluate if the treatment is advisable.</p><p>Ask your doctor or pharmacist for advice before taking any medicine<em>. </em></p><p><strong>Breast-feeding </strong></p><p>Actidol may be used during breast-feeding.</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Important information about some of the ingredients of Actidol , solution for infusion </strong>This medicinal product contains less than 1 mmol sodium (23 mg) per 100 ml of Actidol , i.e. essentially &quot;sodium free&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You should not be given more medicine than the label says. Do not exceed the stated dose.</p><p>Intravenous use.</p><p>Actidol will be administered to you by a healthcare professional by infusion into one of your veins.</p><p>The dose will be individually adjusted by your doctor, based on your weight and general condition.</p><p>The 100 mL vial is restricted to adults, adolescents and children weighing more than 33 kg.</p><p><strong>Dosage </strong></p><p>Dosing based on patient weight (please see the dosing table here below)</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:641px"><tbody><tr><td style="vertical-align:top"><p><strong>Patient weight </strong></p></td><td style="vertical-align:top"><p><strong>Dose &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per </strong></p><p><strong>administration </strong></p></td><td style="vertical-align:top"><p><strong>Volume per </strong></p><p><strong>administration </strong></p></td><td style="vertical-align:top"><p><strong>Maximum volume of Actidol (10 mg/mL) per </strong></p><p><strong>administration based on upper </strong></p><p><strong>weight&nbsp; limits&nbsp; of group (mL)** </strong></p></td><td style="vertical-align:top"><p><strong>Maximum Daily </strong></p><p><strong>Dose *** </strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>&le;10 kg * </strong></p></td><td style="vertical-align:top"><p>7.5 mg/kg</p></td><td style="vertical-align:top"><p>0.75 mL/kg</p></td><td style="vertical-align:top"><p>7.5 mL</p></td><td style="vertical-align:top"><p>30 mg/kg</p></td></tr><tr><td style="vertical-align:top"><p><strong>&gt;10 kg to &le;33 kg </strong></p></td><td style="vertical-align:top"><p>15 mg/kg</p></td><td style="vertical-align:top"><p>1.5 mL/kg</p></td><td style="vertical-align:top"><p>49.5 mL</p></td><td style="vertical-align:top"><p>60 mg/kg not exceeding 2g</p></td></tr><tr><td style="vertical-align:top"><p><strong>&gt;33 kg to &le;50 kg </strong></p></td><td style="vertical-align:top"><p>15 mg/kg</p></td><td style="vertical-align:top"><p>1.5 mL/kg</p></td><td style="vertical-align:top"><p>75 mL</p></td><td style="vertical-align:top"><p>60 mg/kg not exceeding 3g</p></td></tr><tr><td style="vertical-align:top"><p><strong>&gt; 50 kg with additional risk factors for hepatotoxicity </strong></p></td><td style="vertical-align:top"><p>1g</p></td><td style="vertical-align:top"><p>100 mL</p></td><td style="vertical-align:top"><p>100 mL</p></td><td style="vertical-align:top"><p>3g</p></td></tr><tr><td style="vertical-align:top"><p><strong>&gt; 50 kg and no additional risk factors for hepatotoxicity </strong></p></td><td style="vertical-align:top"><p>1g</p></td><td style="vertical-align:top"><p>100 mL</p></td><td style="vertical-align:top"><p>100 mL</p></td><td style="vertical-align:top"><p>4g</p></td></tr></tbody></table><p><strong>* Pre-term newborn infants: </strong>No safety and efficacy data are available for pre-term newborn.</p><p><strong>**Patients weighing less will require smaller volumes. </strong></p><p><strong>The minimum interval between each administration must be at least 4 hours. </strong></p><p><strong>The minimum interval between each administration in patients with severe renal insufficiency must be at least 6 hours. </strong></p><p><strong>No more than 4 doses to be given in 24 hours. </strong></p><p><strong>*** Maximum daily dose: </strong>The maximum daily dose as presented in the table above is for patients that are not receiving other paracetamol containing products and should be adjusted accordingly taking such products into account.</p><p><strong>The paracetamol solution is administered in intravenous infusion over 15 minutes. </strong></p><p>If you have the impression that the effect of Actidol , solution for infusion is too strong or too weak, talk to your doctor.</p><p><strong>If you or your child use more Actidol 10 mg/ml, solution for infusion than if you or your child should use, talk to a doctor at once if you or your child take too much of this medicine even if you or your child seem feel well. This is because too much paracetamol can cause delayed, serious liver damage. </strong></p><p>In overdose cases, symptoms generally appear within the first 24 hours and comprise: nausea, vomiting, anorexia, pallor, abdominal pain and a risk of liver injury.</p><p>If you have any further questions on the use of this product ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Actidol can cause side effects, although not everybody gets them.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In rare cases (more than 1 out of 10,000 persons and less than 1 out of 1,000 persons), the following may occur: a malaise, a drop in blood pressure or changes in laboratory test results: abnormally high levels of hepatic enzymes found during blood checks. Should this occur, inform your doctor as regular blood checks may be required later.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In very rare cases (less than 1 out of 10,000 persons, including isolated reports), a serious skin rash or allergic reaction may occur. Stop the treatment immediately and inform your doctor.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In isolated cases, other changes in laboratory test results have been observed which have necessitated regular blood checks: abnormally low levels of some types of blood cells (platelets, white cells), possibly leading to bleeding from the nose or gums. Should this occur, inform your doctor.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cases of redness of the skin, flushing, itching and abnormally rapid beating of the heart have been reported.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cases of pain and burning sensation at injection site have been reported.</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p><p>Reporting of suspected adverse reactions</p><p>&nbsp;</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions (see details below)</p><p>Reporting of suspected adverse reactions</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia<em>: </em></strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:537px"><tbody><tr><td style="vertical-align:top"><p>The National Pharmacovigilance and Drug Safety Centre (NPC) o SFDA Call Center: 19999</p><p>o E-mail:npc.drug@sfda.gov.sa o Website:https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States: </strong></p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Keep out of reach of children.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Store below 30 &deg;C.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Do not refrigerate or freeze.</p><p><strong>Shelf-life: 24 Months </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; The shelf life is 2 years Actidol vials are for single use only and should be used immediately after opening. Any unused portion in the vial must be discarded.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; After Dilution: From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions are the responsibility of the user.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Before administration, the product should be inspected visually. Don&#39;t use Actidol if you notice any particulate matter and discoloration.</p><p>Do not use beyond the expiry date or if the product shows any sign of deterioration. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Acetaminophen.</p><p><strong>Actidol 1000mg/100mL (10mg/mL) </strong></p><p>Each 100 ml contains Acetaminophen USP 1000mg.</p><p><strong>The other ingredients are: </strong>Mannitol, L-Cysteine Hydrochloride monohydrate, Disodium hydrogen phosphate dehydrate, Hydrochloric acid, Sodium Hydroxide, water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Actidol 1000mg/100mL (10mg/mL)

A Clear, Colorless solution.

How supplied: 
 
Actidol 1000mg/100mL (10mg/mL) 
Injections are supplied in clear moulded infusion glass vials. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Saudi Amarox Industrial Company </strong></p><p>Aljameah Street, Malaz quarter,</p><p>Riyadh 12629, Saudi Arabia</p><p>Tel: +966 11 226 8850</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                February, 2023. 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">هذا الدواء مسكن (يخفف الألم) وخافض للحرارة (يخفض الحمى).</p><p dir="RTL">القارورة سعة 100 مل مخصصة فقط للاستخدام في حالات البالغين والمراهقين والأطفال الذين يزيد وزنهم عن 33 كغم.</p><p dir="RTL">ويتم وصفها للعلاج قصير الأمد في حالات الألم المعتدل، خاصة بعد الجراحة، ولعلاج الحمى على المدى القصير.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم اكتيدول حقن</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية (الحساسية الشديدة) للباراسيتامول أو لأي من مكونات اكتيدول الأخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية (الحساسية الشديدة) من بروباسيتامول (مسكن آخر للحقن من مشتقات الباراسيتامول).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض كبدي حاد.</p><p dir="RTL"><strong>احتياطات خاصة بتناول اكتيدول حقن</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; استخدم العلاج الفموي المسكن المناسب في أقرب وقت ممكن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض في الكبد أو الكلى أو من تعاطي الكحول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أدوية أخرى تحتوي على باراسيتامول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالات مشاكل التغذية (سوء التغذية) أو الجفاف.</p><p dir="RTL">أخبر طبيبك قبل العلاج إذا كانت أي من الحالات المذكورة أعلاه تنطبق عليك.</p><p dir="RTL"><strong>تناول </strong><strong>الأدوية الأخرى و اكتيدول حقن</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يسبب البروبينسيد انخفاضًا يقارب الضعفين في تصفية الباراسيتامول عن طريق تثبيطه بالاقتران بحمض الجلوكورونيك.</p><p dir="RTL">يجب النظر في تقليل جرعة الباراسيتامول اذا تزامن العلاج مع البروبينسيد .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يطيل الساليسيلاميد التخلص من 1/2 من الباراسيتامول.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب توخي الحذر عند تناول المواد المسببة للإنزيم (</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يؤدي الاستخدام المتزامن للباراسيتامول (4 جم يوميًا لمدة 4 أيام على الأقل) مع مضادات التخثر الفموية إلى الاختلافات الطفيفة في قيم INR خلال فترة الاستخدام المتزامن وكذلك لمدة أسبوع بعد التوقف عن العلاج بالباراسيتامول.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يؤدي تناول الفينيتوين بشكل متزامن إلى انخفاض فعالية الباراسيتامول و زيادة خطر تسمم الكبد.</p><p dir="RTL">يجب على المرضى الذين يتلقون العلاج بالفينيتوين تجنب تناول كميات كبيرة و / أو جرعات مزمنة من الباراسيتامول. يجب مراقبة المرضى بحثًا عن دليل على التسمم الكبدي.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب توخي الحذر عند تناول ما يصاحب ذلك من العوامل المسببة للإنزيم. هذه المواد تشمل على سبيل المثال لا الحصر: الباربيتورات ، الإيزونيازيد ، مضادات التخثر ، زيدوفودين ، أموكسيسيلين + حمض كلافولانيك ، كاربامازيبين وإيثانول. تحريض استقلاب الباراسيتامول من محرضات الإنزيم قد يؤدي إلى زيادة مستوى المستقلبات السامة للكبد.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بوسلفان - يتم التخلص من بوسولفان من الجسم عن طريق الاقتران مع الجلوتاثيون. ما قد يؤدي الباراسيتامول إلى تقليل إزالة البوزولفان. Diflunisal - ما يصاحب ذلك من فرق يزيد من تركيزات الباراسيتامول في البلازما وهذا قد يزيد من تسمم الكبد &quot;.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">إذا كنت حاملاً أو مرضعة، تعتقدين أنك حامل أو تخططين لإنجاب طفل، اسألي طبيبك أو الصيدلي للحصول على المشورة قبل تناول هذا الدواء.</p><p dir="RTL"><strong>الحمل</strong></p><p dir="RTL">أخبر طبيبك إذا كنت حاملا. يمكن استخدام اكتيدول حقن أثناء الحمل. ومع ذلك، في هذه الحالة يجب على الطبيب تقييم ما إذا كان العلاج باستخدام اكتيدول حقن أثناء الحمل مستحسناً.</p><p dir="RTL">اسأل طبيبك أو الصيدلي للحصول على المشورة قبل تناول أي دواء.</p><p dir="RTL"><strong>الرضاعة الطبيعية</strong></p><p dir="RTL">يمكن استخدام اكتيدول حقن أثناء الرضاعة الطبيعية.</p><p dir="RTL">اسأل طبيبك أو الصيدلي للحصول على المشورة قبل تناول أي دواء.</p><p dir="RTL"><strong>معلومات مهمة عن بعض مكونات اكتيدول محلول التسريب الوريدي</strong></p><p dir="RTL">يحتوي هذا المنتج الطبي على أقل من 1 مليمول صوديوم (23 ملغم) لكل 100 مل من اكتيدول، أي بشكل أساسي &quot;خال من الصوديوم&quot;.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عدم تناول جرعة زائدة من اكتيدول حقن أكثر من الجرعة الموصوفة لك. لا تتعدى الجرعة المحددة.</p><p dir="RTL"><strong>الاستخدام عن طريق الحقن الوريدي.</strong></p><p dir="RTL">سيتم إعطاء اكتيدول محلول التسريب الوريدي لك من قبل أخصائي الرعاية الصحية عن طريق الحقن في أحد الأوردة.</p><p dir="RTL">سيتم تعديل الجرعة بشكل فردي من قبل طبيبك، بناءً على وزنك وحالتك العامة.</p><p dir="RTL">القارورة سعة 100 مل مخصصة للاستخدام في حالات البالغين والمراهقين والأطفال الذين يزيد وزنهم عن 33 كغم.</p><p dir="RTL"><strong>الجرعة</strong></p><p dir="RTL">يتم تحديد الجرعات على أساس وزن المريض (يرجى الاطلاع على جدول الجرعات أدناه)</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p dir="RTL"><strong>وزن المريض</strong></p></td><td><p dir="RTL"><strong>الجرعة</strong></p></td><td><p dir="RTL"><strong>كمية المحلول لكل جرعة</strong></p></td><td><p dir="RTL"><strong>الجرعة القصوى من اكتيدول (10 ملغم/مل) والتي يتم وصفها على أساس الحد الأقصى للوزن (مل) **</strong></p></td><td><p dir="RTL"><strong>الجرعة اليومية القصوى ***</strong></p></td></tr><tr><td><p dir="RTL">&le;10 كغم *</p></td><td><p dir="RTL">7.5 ملغم / كغم</p></td><td><p dir="RTL">0.75 مل / كغم</p></td><td><p dir="RTL">7.5 مل</p></td><td><p dir="RTL">30 ملغم / كغم</p></td></tr><tr><td><p dir="RTL">&gt; 10 كغم إلى 33 كغم</p></td><td><p dir="RTL">15 ملغم / كغم</p></td><td><p dir="RTL">1.5 مل / كغم</p></td><td><p dir="RTL">49.5 مل</p></td><td><p dir="RTL">60 ملغم / كغم لا تزيد عن 2 جرام</p></td></tr><tr><td><p dir="RTL">&gt; 33 كغم إلى -50 كغم</p></td><td><p dir="RTL">15 ملغم / كغم</p></td><td><p dir="RTL">1.5 مل / كغم</p></td><td><p dir="RTL">75 مل</p></td><td><p dir="RTL">60 ملغم / كغم لا تزيد عن 3 جرام</p></td></tr><tr><td><p dir="RTL">&gt; 50 كغم مع عوامل خطر إضافية للتسمم الكبدي</p></td><td><p dir="RTL">1 جرام</p></td><td><p dir="RTL">100 مل</p></td><td><p dir="RTL">100 مل</p></td><td><p dir="RTL">3 جرام</p></td></tr><tr><td><p dir="RTL">&gt; 50 كغم ولا توجد عوامل خطر إضافية للسمية الكبدية</p></td><td><p dir="RTL">1 جرام</p></td><td><p dir="RTL">100 مل</p></td><td><p dir="RTL">100 مل</p></td><td><p dir="RTL">4 جرام</p></td></tr></tbody></table><p dir="RTL">* الأطفال حديثي الولادة: لا تتوفر بيانات سلامة وفعالية لحديثي الولادة المبكرة.</p><p dir="RTL">** سيحتاج المرضى الذين يقل وزنهم عن الوزن الطبيعي إلى جرعات أقل.</p><p dir="RTL">يجب أن يكون الحد الأدنى للفاصل الزمني بين كل استخدام 4 ساعات على الأقل، لا يجوز إعطاء أكثر من 4 جرعات خلال 24 ساعة.</p><p dir="RTL">يجب أن يكون الحد الأدنى للفاصل الزمني بين كل استخدام في المرضى الذين يعانون من قصور كلوي حاد 6 ساعات على الأقل.</p><p dir="RTL">*** الجرعة اليومية القصوى: الحد الأقصى للجرعة اليومية كما هو موضح في الجدول أعلاه للمرضى الذين لا يتناولون أدوية أخرى تحتوي على الباراسيتامول ويجب تعديلها وفقًا لذلك مع مراعاة هذه المنتجات.</p><p dir="RTL">يُعطى محلول الباراسيتامول بالتسريب الوريدي لمدة 15 دقيقة.</p><p dir="RTL">إذا كان لديك انطباع بأن تأثير اكتيدول محلول التسريب قوي جدًا أو ضعيف جدًا، تحدث إلى طبيبك.</p><p dir="RTL">إذا كنت قد تناولت أنت أو طفلك جرعة زائدة من اكتيدول محلول التسريب الوريدي أكثر مما ينبغي، فاتصل بطبيبك على الفور بمجرد تناولك أنت أو طفلك للجرعة الزائدة حتى لو شعرت أنت أو طفلك أنكم بخير. وذلك لأن الجرعة الزائدة من الباراسيتامول يمكن أن تسبب تلف الكبد المتأخر والخطير.</p><p dir="RTL">في حالات الجرعة الزائدة، تظهر الأعراض بشكل عام خلال الـ 24 ساعة الأولى وتشمل: الغثيان والقيء وفقدان الشهية والشحوب وآلام البطن وخطر إصابة الكبد.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يسبب هذا الدواء آثارًا جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالات نادرة (أكثر من شخص من بين 10000 شخص وأقل من شخص من كل 1000 شخص)، قد يحدث ما يلي: الشعور بالضيق أو انخفاض ضغط الدم أو تغيرات في نتائج الاختبارات المعملية: مستويات عالية بشكل غير طبيعي من الإنزيمات الكبدية التي تم العثور عليها أثناء فحوصات الدم. في حالة حدوث ذلك، أخبر طبيبك حيث قد تكون هناك حاجة لفحوصات الدم المنتظمة في وقت لاحق.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالات نادرة جدًا (أقل من شخص واحد من بين 10000 شخص، بما في ذلك التقارير المنفردة)، قد يحدث طفح جلدي خطير أو تفاعل تحسسي. يجب وقف العلاج فورًا وأبلغ طبيبك.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالات معزولة، لوحظت تغيرات أخرى في نتائج الفحوصات المخبرية والتي استدعت إجراء فحوصات دم منتظمة: مستويات منخفضة بشكل غير طبيعي في بعض أنواع خلايا الدم (الصفائح الدموية، خلايا الدم البيضاء)، مما قد يؤدي إلى نزيف من الأنف أو اللثة. في حالة حدوث ذلك، أخبر طبيبك.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تم الإبلاغ عن حالات احمرار في الجلد واحمرار وحكة وسرعة ضربات القلب بشكل غير طبيعي.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تم الإبلاغ عن حالات ألم وحرقان في موقع الحقن.</p><p dir="RTL">إذا تفاقمت أي من الآثار الجانبية، أو إذا لاحظت أي آثار جانبية غير مدرجة في هذه النشرة، فيرجى إخبار طبيبك أو الصيدلي.</p><p><strong>الإبلاغ عن الآثار الجانبية: </strong></p><p>إذا زادت حدة أي من هذه الأعراض الجانبية، أو لاحظت ظهور أعراض جانبية غير ما تم ذكره في هذه النشرة، يرجى إبلاغ الطبيب المعالج أو الصيدلي. وهذا يشمل أي آثار جانبية محتملة غير مدرجة في هذه النشرة. يمكنك أيضا الإبلاغ عن الآثار الجانبية مباشرة (انظر التفاصيل أدناه). بالإبلاغ عن الآثار الجانبية يمكنك المساعدة في توفير مزيد من المعلومات حول أمان هذا الدواء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المملكة العربية السعودية:</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ الدوائي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز الاتصال بالهيئة العامة للغذاء والدواء 19999:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني npc.drug@sfda.gov.sa:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p></td></tr></tbody></table><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دول الخليج العربي الأخرى:</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الاتصال بالجهات الوطنية في كل دولة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ هذا الدواء بعيدًا عن رؤية ومتناول أيدي الأطفال.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30 درجة مئوية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تقم بالتبريد أو التجميد.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قارورة اكتيدول للتسريب الوريدي للاستخدام الفردي فقط ويجب استخدامها مباشرة بعد الفتح. يجب التخلص من أي كمية متبقية في القارورة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعد التخفيف: &quot;من وجهة نظر الميكروبيولوجي&quot; يجب استخدام المنتج على الفور. إذا لم يتم استخدامه على الفور، فإن أوقات وشروط التخزين أثناء الاستخدام هي مسؤولية المستخدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قبل الاستخدام، يجب فحص المنتج بصريًا. لا تستخدم اكتيدول إذا لاحظت أي جسيمات أو تغير في اللون.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة بعد EXP. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص من الأدوية في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ماذا تحتوي اكتيدول حقن على:</strong></p><p dir="RTL">المادة الفعالة هي اسيتامينوفين.</p><p dir="RTL"><strong>اكتيدول حقن 1000 ملغم/ 100 مل (10 مجم / مل):</strong></p><p dir="RTL">يحتوي كل 100 مل على أسيتامينوفين 1000 ملغم.</p><p dir="RTL">الصواغات الأخرى هي: مانيتول، إل-سيستينن هيدروكلوريد أحادي الهيدرات، فوسفات&nbsp;ثنائي&nbsp;الصوديوم احادي الهيدرات، حمض الهيدروكلوريك، هيدروكسيد الصوديوم، ماء للحقنز</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ما هو شكل اكتيدول حقن؟</strong></p><p dir="RTL"><strong>اكتيدول حقن 1000 ملغم/ 100 مل (10 مجم / مل):</strong></p><p dir="RTL">محلول نقي وعديم اللون.</p><p dir="RTL"><strong>كيفية توفير اكتيدول حقن؟</strong></p><p dir="RTL">يتم توفير اكتيدول حقن في قوارير زجاجية شفافة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شركة اماروكس السعودية الصناعية</strong></p><p>شارع الجامعة &ndash; الملز &ndash; الرياض 12629</p><p>المملكة العربية السعودية.</p><p dir="RTL">تليفون: +9660112268850</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            فبراير 2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Actidol 1000mg/100mL (Acetaminophen Injection 1000mg/100mL (10mg/mL)) 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 100 ml contains Acetaminophen USP 1000mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                A Clear, Colorless solution. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Actidol&nbsp; is indicated for the short-term treatment of moderate pain, especially following surgery&nbsp; and for the short-term treatment of fever, when administration by intravenous route is clinically&nbsp; justified by an urgent need to treat pain or hyperthermia and/or when other routes of&nbsp; administration are not possible.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Intravenous route.&nbsp;</p><p>The 100 mL vial is restricted to adults, adolescents and children weighing more than 33 kg.&nbsp;</p><p>Posology:&nbsp;</p><p>Dosing based on patient weight (please see the dosing table here below)&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:641px"><tbody><tr><td style="vertical-align:top"><p><strong>Patient weight</strong></p></td><td style="vertical-align:top"><p><strong>Dose &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per </strong></p><p><strong>administration</strong></p><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Volume &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per </strong></p><p><strong>administration</strong></p><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Maximum volume of Actidol (10 mg/mL) per </strong></p><p><strong>administration based on upper </strong></p><p><strong>weight limits of group (mL)**</strong></p></td><td style="vertical-align:top"><p><strong>Maximum Daily </strong></p><p><strong>Dose ***</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>&le;10 kg *</strong></p></td><td style="vertical-align:top"><p>7.5 mg/kg</p></td><td style="vertical-align:top"><p>0.75 mL/kg</p></td><td style="vertical-align:top"><p>7.5 mL</p></td><td style="vertical-align:top"><p>30 mg/kg</p></td></tr><tr><td style="vertical-align:top"><p><strong>&gt;10 kg to &le;33 kg</strong></p></td><td style="vertical-align:top"><p>15 mg/kg</p></td><td style="vertical-align:top"><p>1.5 mL/kg</p></td><td style="vertical-align:top"><p>49.5 mL</p></td><td style="vertical-align:top"><p>60 mg/kg not exceeding 2g</p></td></tr><tr><td style="vertical-align:top"><p><strong>&gt;33 kg to &le;50 kg</strong></p></td><td style="vertical-align:top"><p>15 mg/kg</p></td><td style="vertical-align:top"><p>1.5 mL/kg</p></td><td style="vertical-align:top"><p>75 mL</p></td><td style="vertical-align:top"><p>60 mg/kg not exceeding 3g</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:641px"><tbody><tr><td style="vertical-align:top"><p><strong>Patient weight</strong></p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Dose per administration</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Volume per administration</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Maximum volume &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per</p><p>administration **</p></td><td style="vertical-align:top"><p>Maximum Daily</p><p>Dose ***</p></td></tr><tr><td style="vertical-align:top"><p><strong>&gt; 50 kg with additional risk factors for hepatotoxicity</strong></p></td><td style="vertical-align:top"><p>1g</p></td><td style="vertical-align:top"><p>100 mL</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>100 mL</p></td><td style="vertical-align:top"><p>3 g</p></td></tr><tr><td style="vertical-align:top"><p><strong>&gt; 50 kg and no additional risk factors for hepatotoxicity</strong></p></td><td style="vertical-align:top"><p>1 %</p></td><td style="vertical-align:top"><p>100 mL</p></td><td style="vertical-align:top"><p>100 mL</p></td><td style="vertical-align:top"><p>4 g</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>* Pre-term newborn infants: No safety and efficacy data are available for pre-term newborn infants&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (see section 5.2).</p><p>** Patients weighing less will require smaller volumes.</p><p>The minimum interval between each administration must be at least 4 hours. No more than 4 doses to be given in 24 hours.&nbsp;</p><p>The minimum interval between each administration in patients with severe renal insufficiency must be at least 6 hours.&nbsp;</p><p>*** Maximum daily dose: The maximum daily dose as presented in the table above is for patients that are not receiving other paracetamol containing products and should be adjusted accordingly taking such products into account Severe renal insufficiency:&nbsp;</p><p>It is recommended, when giving paracetamol to patients with severe renal impairment (creatinine clearance &le; 30 mL/min), to increase the minimum interval between each administration to 6 hours (See section 5.2).</p><p>In adults with hepatocellular insufficiency, chronic alcoholism, chronic malnutrition (low reserves of hepatic glutathione), dehydration.&nbsp;</p><p>The maximum daily dose must not exceed 3 g (see section 4.4).</p><p><strong>Method of administration: </strong></p><p>Take care when prescribing and administering Actidol to avoid dosing errors due to confusion between milligram (mg) and milliliter (mL), which could result in accidental overdose and death. Take care to ensure the proper dose is communicated and dispensed. When writing prescriptions, include both the total dose in mg and the total dose in volume.</p><p>The paracetamol solution is administered as a 15-minute intravenous infusion.</p><p>Patients weighing &le; 10 kg:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The glass vial of Actidol should not be hung as an infusion due to the small volume of the&nbsp;medicinal product to be administered in this population</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The volume to be administered should be withdrawn from the vial and could be&nbsp; administered&nbsp;undiluted or diluted (from one to nine volumes diluent) in a 0.9% sodium chloride solution or 5% glucose solution and administered in 15 minute.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use the diluted solution within the hour following its preparation (infusion time&nbsp;&nbsp; included).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A 5 or 10 ml syringe should be used to measure the dose as appropriate for the weight of&nbsp;&nbsp; the child and the desired volume. However, this should never exceed 7.5ml per dose</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The user should be referred to the product information for dosing guidelines.</p><p><u>Text for the 50ml and 100ml vials:</u></p><p>To remove solution, use a 0.8 mm needle (21 gauge needle) and vertically perforate the stopper at the spot specifically indicated.</p><p>As for all solutions for infusion presented in glass vials, it should be remembered that close monitoring is needed notably at the end of the infusion, regardless of administration route. This monitoring at the end of the perfusion applies particularly for central route infusion, in order to avoid air embolism</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Actidol is contraindicated: 
•	In patients with hypersensitivity to paracetamol or to propacetamol hydrochloride (prodrug of    paracetamol) or to one of the excipients.  
•	In cases of severe hepatocellular insufficiency. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Warnings</p><p>RISK OF MEDICATION ERRORS</p><p>Take care to avoid dosing errors due to confusion between milligram (mg) and millilitre (mL), which could result in accidental overdose and death (see section 4.2).</p><p>It is recommended to use a suitable analgesic oral treatment as soon as this administration route is possible.</p><p>In order to avoid the risk of overdose, check that other medicines administered do not contain either paracetamol or propacetamol.</p><p>Doses higher than the recommended entails risk for very serious liver damage. Clinical symptoms and signs of liver damage (including fulminant hepatitis, hepatic failure, cholestatic hepatitis, cytolytic hepatitis) are usually first seen after two days of drug administration with a peak seen usually after 4 - 6 days. Treatment with antidote should be given as soon as possible (See section 4.9).</p><p><strong>This medicinal product contains less than 1 mmol sodium (23mg) per 100 mL of Actidol, i.e. </strong></p><p><strong>essentially &quot;sodium free&quot;. </strong></p><p>Text for the 50ml and 100ml vials:<strong> </strong></p><p>As for all solutions for infusion presented in glass vials, a close monitoring is needed notably at the end of the infusion (see section 4.2).</p><p>Precautions for use</p><p>Paracetamol should be used with caution in cases of:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatocellular insufficiency.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe renal insufficiency (creatinine clearance &le; 30 mL/min) (see sections 4.2 and 5.2).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chronic alcoholism.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chronic malnutrition (low reserves of hepatic gluthatione).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dehydration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Probenecid causes an almost 2-fold reduction in clearance of paracetamol by inhibiting its&nbsp;&nbsp; conjugation with glucuronic acid. A reduction of the paracetamol dose should be considered for concomitant treatment with probenecid,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Salicylamide may prolong the elimination t1/2 of paracetamol,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Caution should be paid to the concomitant intake of enzyme-inducing substances (see section&nbsp;&nbsp;&nbsp;4.9).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Concomitant use of paracetamol (4 g per day for at least 4 days) with oral anticoagulants may lead&nbsp; to slight variations of INR values should be conducted during the period of concomitant use as well as for 1 week after paracetamol treatment has been discontinued.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phenytoin administered concomitantly may result in decreased paracetamol effectiveness and an increased risk of hepatotoxicity. Patients receiving phenytoin therapy should avoid large and/or chronic doses of paracetamol. Patients should be monitored for evidence of hepatotoxicity. Caution should be paid to the concomitant intake of enzyme-inducing agents. These substances include but are not limited to: barbiturates, isoniazid, anticoagulants, zidovudine, amoxicillin+clavulanic acid, carbamazepine and ethanol. Induction of metabolism of paracetamol from enzyme inducers may result in an increased level of hepatotoxic metabolites. Busulfan - busulfan is eliminated from the body via conjugation with glutathione. Concomitant use with paracetamol may result in reduced busulfan clearance. Diflunisal - concomitant diflunisal increases paracetamol plasma concentrations and this may increase hepatotoxicity.&rdquo;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clinical experience of intravenous administration of paracetamol is limited. However, epidemiological data from the use of oral therapeutic doses of paracetamol indicate&nbsp; no undesirable effects on the pregnancy or on the health of the foetus / newborn infant.</p><p>Prospective data on pregnancies exposed to overdoses did not show an increase in malformation risk.</p><p>Reproductive studies with the intravenous form of paracetamol have not been performed in animals.</p><p>However, studies with the oral route did not show any malformation of foetotoxic effects.</p><p>Nevertheless, Actidol should only be used during pregnancy after a careful benefit-risk assessment.</p><p>In this case, the recommended posology and duration must be strictly observed.</p><p><strong>Lactation: </strong></p><p>After oral administration, paracetamol is excreted into breast milk in small quantities. No undesirable effects on nursing infants have been reported.</p><p>Consequently, Actidol may be used in breast-feeding women.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As all paracetamol products, adverse drug reactions are rare (&gt;1/10000, &lt;1/1000) or very rare (&lt;1/10000), they are described below:</p><table border="0" cellspacing="0" cellpadding="0" style="width:665px"><tbody><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Organ system</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="4" rowspan="2" style="vertical-align:top"><p>Rare</p><p>&gt;1/10000, &lt;1/1000</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" rowspan="2" style="vertical-align:top"><p>Very rare</p><p>&lt;1/10000</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p>General</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Malaise</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypersensitivity reaction</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="4" style="vertical-align:top"><p>Cardiovascular</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p>Hypotension</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Liver</p></td><td colspan="3" rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Increased &nbsp;&nbsp; levels &nbsp;&nbsp; of</p></td><td style="vertical-align:top"><p>hepatic</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>transaminases</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Platelet/blood</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="4" rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" rowspan="2" style="vertical-align:top"><p>Thrombocytopenia,</p><p>Leucopenia,</p><p>Neutropenia</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p>Frequent adverse reactions at injection site have been reported during clinical trials (pain and burning sensation).</p><p>Very rare cases of hypersensitivity reactions ranging from simple skin rash or urticaria to anaphylactic shock have been reported and require discontinuation of treatment.</p><p>Cases of erythema, flushing, pruritus and tachycardia have been reported.</p><p><u>Reporting of suspected adverse reactions</u>&nbsp;</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions (see details below)&nbsp;</p><p><u>Reporting of suspected adverse reactions</u>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia<em>: </em></strong></p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p><strong><em>&nbsp;</em></strong>o SFDA Call Center: 19999</p><p><strong><em>&nbsp;</em></strong>o &nbsp;E-mail:npc.drug@sfda.gov.sa <strong><em>&nbsp;</em></strong>o Website:https://ade.sfda.gov.sa/</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is a risk of liver injury (including fulminant hepatitis, hepatic failure, cholestatic hepatitis, cytolytic hepatitis), particularly in elderly subjects, in young children, in patients with liver disease, in cases of chronic alcoholism, in patients with chronic malnutrition and in patients receiving enzyme inducers. Overdosing may be fatal in these cases.</p><p>Symptoms generally appear within the first 24 hours and comprise: nausea, vomiting, anorexia, pallor, abdominal pain. Overdose, 7.5 g or more of paracetamol in a single administration in adults and 140 mg/kg of body weight in a single administration in children, causes hepatic cytolysis likely to induce complete and irreversible necrosis, resulting in hepatocellular insufficiency, metabolic acidosis and encephalopathy which may lead to coma and death.</p><p>Simultaneously, increased levels of hepatic transaminases (AST, ALT), lactate dehydrogenase and bilirubin are observed together with decreased prothrombin levels that may appear 12 to 48 hours after administration.</p><p>Clinical symptoms of liver damage are usually evident initially after two days, and reach a maximum after 4 to 6 days.</p><p><u>Emergency measures</u></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Immediate hospitalisation.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Before beginning treatment, take a tube of blood for plasma paracetamol assay, as soon as possible&nbsp; after the overdose.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The treatment includes administration of the antidote, N-acetylcysteine (NAC), by the i.v. or oral route, if possible before the 10th hour. NAC can, however, give some degree protection even after 10 hours, but in these cases prolonged treatment is given.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Symptomatic treatment.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatic tests must be carried out at the beginning of treatment and repeated every 24 hours. In most cases hepatic transaminases return to normal in one to two weeks with full restitution of liver function. In very severe cases, however, liver transplantation may be necessary.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5.1 Pharmacodynamic properties</p><p>Pharmacotherapeutic group: other analgesics and antipyretics.</p><p><strong>ATC code: N02BE01</strong></p><p>The precise mechanism of the analgesic and antipyretic properties of paracetamol has yet to be established; it may involve central and peripheral actions.</p><p>Paracetamol provides onset of pain relief within 5 to 10 minutes after the start of administration.</p><p>The peak analgesic effect is obtained in 1 hour and the duration of this effect is usually 4 to 6 hours. Paracetamol reduces fever within 30 minutes after the start of administration with a duration of the antipyretic effect of at least 6 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption:</strong></p><p>Paracetamol pharmacokinetics is linear up to 2 g after single administration and after repeated administration during 24 hours.</p><p>The bioavailability of paracetamol following infusion of 500 mg and 1 g of&nbsp; Actidol is similar to that observed following infusion of 1 g and 2 g propacetamol (corresponding to 500 mg and 1 g paracetamol respectively). The maximal plasma concentration (Cmax) of paracetamol observed at the end of 15-minutes intravenous infusion of 500 mg and 1 g of ACTIDOL is about 15 &mu;g/mL and 30 &mu;g/mL respectively.</p><p><strong>Distribution:</strong></p><p>The volume of distribution of paracetamol is approximately 1 L/kg.</p><p>Paracetamol is not extensively bound to plasma proteins.</p><p>Following infusion of 1 g paracetamol, significant concentrations of paracetamol (about 1.5 &mu;g/mL) were observed in the Cerebro Spinal Fluid as and from the 20<sup>th</sup> minute following infusion.</p><p><strong>Metabolism:</strong></p><p>Paracetamol is metabolised mainly in the liver following two major hepatic pathways: glucuronic acid conjugation and sulphuric acid conjugation. The latter route is rapidly saturable at doses that exceed the therapeutic doses. A small fraction (less than 4%) is metabolised by cytochrome P450 to a reactive intermediate (N-acetyl benzoquinone imine) which, under normal conditions of use, is rapidly detoxified by reduced glutathione and eliminated in the urine after conjugation with cysteine and mercapturic acid. However, during massive overdosing, the quantity of this toxic metabolite is increased.</p><p><strong>Elimination:</strong></p><p>The metabolites of paracetamol are&nbsp; mainly excreted in the urine. 90% of the dose administered is excreted in 24 hours, mainly as glucuronide (60-80%) and sulphate (20-30%) conjugates. Less than 5% is&nbsp; eliminated unchanged. Plasma half-life is 2.7 hours and total body clearance is 18 L/h.</p><p><strong>Neonates, infants and children</strong></p><p>The pharmacokinetic parameters of paracetamol observed in infants and children are similar to those observed in adults, except for the plasma half-life that is slightly shorter (1.5 to 2 h) than in adults. In neonates, the plasma half-life is longer than in infants i.e. around 3.5 hours. Neonates, infants and children up to 10 years excrete significantly less glucuronide and more sulphate conjugates than adults.</p><p>Table. Age related pharmacokinetic values (standardized clearance,*CL<sub>std</sub>/F<sub>oral</sub> (l.h<sup>-1</sup> 70 kg<sup>-1</sup>), are presented below.</p><table border="0" cellspacing="0" cellpadding="0" style="width:654px"><tbody><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Age</p></td><td style="vertical-align:top"><p>Weight (kg)</p></td><td><p>CLstd/Foral (l.h-1 70 kg-1)</p></td><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>40 weeks PCA</p><p>3 months PNA</p><p>6 months PNA</p><p>1&nbsp; year PNA</p><p>2&nbsp; years PNA</p><p>5 years PNA</p><p>8 years PNA</p></td><td style="vertical-align:top"><p>3.3</p><p>6</p><p>7.5</p><p>10</p><p>12</p><p>20</p><p>25</p></td><td style="vertical-align:top"><p>5.9</p><p>8.8</p><p>11.1</p><p>13.6</p><p>15.6</p><p>16.3</p><p>16.3</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>*CL<sub>std</sub> is the population estimate for CL</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>Special populations:</p><p><strong>Renal insufficiency</strong></p><p>In cases of severe renal impairment (creatinine clearance 10-30 mL/min), the elimination of paracetamol is slightly delayed, the elimination half-life ranging from 2 to 5.3 hours. For the glucuronide and sulphate conjugates, the elimination rate is 3 times slower in subjects with severe renal impairment than in healthy subjects. Therefore, it is recommended, when giving paracetamol to patients with severe renal impairment (creatinine clearance &le; 30 mL/min), to increase the minimum interval between each administration to 6 hours (see section 4.2. Posology and method of administration).</p><p><strong>Elderly subjects</strong></p><p>The pharmacokinetics and the metabolism of paracetamol are not modified in elderly subjects. No dose adjustment is required in this population</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard for humans beyond the information included in other sections of the SmPC.</p><p>Studies on local tolerance of paracetamol in rats and rabbits showed good tolerability. Absence of delayed contact hypersensitivity has been tested in guinea pigs.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mannitol, L-Cysteine Hydrochloride monohydrate, Disodium hydrogen phosphate dehydrate, Hydrochloric acid, Sodium Hydroxide, water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product must not be mixed with other medicinal products</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months 
The shelf life is 2 years Actidol vials are for single use only and should be used immediately after opening. Any unused portion in the vial must be discarded. After Dilution: From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions are the responsibility of the user.  

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C.</p><p>Do not refrigerate or freeze.</p><p>For storage conditions after dilution of the medicinal product see section 6.3</p><p>Do not use beyond the expiry date or if the product shows any sign of deterioration</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Actidol 1000mg/100mL: 100 mL Clear Moulded Infusion Glass Vial, USP Type-I with 32 mm neck, Stopper 32 mm Slotted GBB 6720GC 6TP3 (RTS), Flip off Seal Matte Top Green 32, packaged in carton with folded leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Use a 0.8 mm needle and vertically perforate the stopper at the spot specifically indicated.</p><p>Before administration, the product should be visually inspected for any particulate matter and discoloration.</p><p>For single use only. Any unused solution should be discarded.</p><p>The diluted solution should be visually inspected and should not be used in presence of opalescence, visible particulate matters or precipitate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aljameah Street, Malaz quarter,  
Riyadh 11441, Saudi Arabia  
Tel: +966 11 477 2215  
Manufacture: Aspiro Pharma Limited, Hyderabad, India 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April, 2023. 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>